Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002562

Director bought 2,500 shares at $1.70 ($4,250)

From the SEC's structured data for this filing

Trades in this filing

Gumulka Jerzy · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-19 Purchase : show line 1 in the form +2,500 $1.70 $4,250 9,673 D
Open-market purchases · 2,500 sh · avg $1.70 · $4,250
Loading xslF345X04/ownership.xml…